Vir Biotechnology Inc (VIR)
Vir Biotechnology stock today
Vir Biotechnology closed at $11.30 on October 30, 2026, down 3.83% on the day. Over the past year it returned +90.6% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.91 billion.
| Period | VIR | S&P 500 (SPY) |
|---|---|---|
| 1 month | +1.1% | -0.9% |
| 3 months | +27.0% | +2.1% |
| Year to date | +87.4% | +11.7% |
| 1 year | +90.6% | +12.4% |
| 3 years | +40.4% | +88.5% |
| 5 years | -70.1% | +76.0% |
Key statistics
- Market value
- $1.91B
- Price / sales
- 6.3
- 52-week range
- $5.12 to $11.93
- Next report
- Nov 4, 2026
About Vir Biotechnology
Develops and commercializes antiviral medicines for serious infectious diseases.
Sector: Health Care
More on Vir Biotechnology
- Financials: revenue, earnings and segmentsRevenue -8% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $299.50 today
No forecast, no recommendation. This page describes Vir Biotechnology Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.